Imago BioSciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Imago BioSciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2022.
  • Imago BioSciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $772K, a 1444% increase year-over-year.
  • Imago BioSciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $1.26M.
  • Imago BioSciences, Inc. annual Nonoperating Income (Expense) for 2021 was $215K, a 11.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.26M $772K +$722K +1444% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $534K $275K +$239K +664% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $295K $119K +$80K +205% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $215K $90K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-24
Q3 2021 $50K +$48K +2400% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $36K -$237K -86.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $39K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $2K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $273K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.